GPI SpACHIX:GPIM 78 EBITDA Margin % is 20.07% as of Dec. 2025, which is 51% above its 10-year median of 13.33. GuruFocus rates CHIX:GPIM with a GF Score™ of 78/100 and a GF Value™ of €18.64. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, GPI SpA ranks better than 70.51% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. GPI SpA's EBITDA for the
six
months ended in Dec. 2025 was €59.0 Mil. GPI SpA's Revenue for the
six
months ended in Dec. 2025 was €293.9 Mil. Therefore, GPI SpA's EBITDA margin for the quarter that ended in Dec. 2025 was 20.07%.
GPI SpA (CHIX:GPIm) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
GPI SpA EBITDA Margin % Related Terms
GPI SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for GPI SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:GPIM vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, GPI SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPI SpA EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPI SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where GPI SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPI SpA (CHIX:GPIM) has a EBITDA Margin % of 20.07% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GPI SpA and its competitors. This is 51% above median its historical median of 13.33. Over the past decade, GPI SpA's EBITDA Margin % has ranged from 12.48 to 19.57. According to the industry distribution chart, GPI SpA ranks #197 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 29.5%.
Is GPI SpA's EBITDA Margin % too high?
GPI SpA's current EBITDA Margin % of 20.07% is 51% above median its 10-year median of 13.33. Over the past 10 years, this metric has ranged from a low of 12.48 to a high of 19.57. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. GPI SpA's value of 20.07% is 96.6% above this industry median. Based on the distribution chart, GPI SpA ranks #197 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GPI SpA has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does GPI SpA's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GPI SpA ranks #197 out of 668 companies for EBITDA Margin %. This puts GPI SpA in the upper half of its industry. The industry median EBITDA Margin % is 10.21. GPI SpA's value of 20.07% is 96.6% above this benchmark. Historically, GPI SpA's own EBITDA Margin % has ranged from 12.48 to 19.57 over the past decade. While the company's 10-year median is 13.33 vs. the industry median of 10.21, GPI SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPI SpA's current EBITDA Margin % of 20.07% is 96.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on GPI SpA and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPI SpA's current EBITDA Margin % is 20.07%, which is 51% above median its own 10-year median of 13.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPI SpA stock overvalued right now?
GPI SpA (CHIX:GPIM) has a current EBITDA Margin % of 20.07%. The stock's GF Value™ is €18.64, compared to a current price of €17.00 — trading 8.8% below its estimated fair value. The current EBITDA Margin % is 20.07%, which is 51% above median its 10-year median of 13.33 and 96.6% above the Healthcare Providers & Services industry median of 10.21. GPI SpA's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For GPI SpA (CHIX:GPIM), the current EBITDA Margin % is 20.07% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GPI SpA (CHIX:GPIM) Overvalued in 2026?
Based on GuruFocus' analysis, GPI SpA stock appears to be undervalued.
The current stock price of €17.00 is trading 8.8% below its estimated GF Value™ of €18.64.
Key valuation signals for CHIX:GPIM:
EBITDA Margin %: 20.07% (51% above median its 10-year median of 13.33)
GF Value™: €18.64 vs. price of €17.00 (8.8% below fair value)
Industry Position: 96.6% above the Healthcare Providers & Services median (#197 of 668)
No single metric tells the full story. See the CHIX:GPIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GPI SpA operates in the field of social-healthcare IT services and hi-tech services for health. It provides services in the areas of IT systems, healthcare, pharmacy logistics, electronic payment solutions, and ICT infrastructures and systemic services.
78GF Score
Get the complete analysis for CHIX:GPIM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:GPIM has been successfully added to your 
